Introduction With the promotion of robotic approaches for hepatopancreatobiliary in recent international guidelines, Australian data regarding the uptake of robotic procedures is lacking. The aim of this study is to examine the volume of hepatopancreatobiliary surgery in Australia and its robotic case volume. Methods Data from patients undergoing robotic hepatopancreatobiliary surgery on the da Vinci platforms were obtained from Device TechnologiesTM from 2016 to 2023. The total volume of specific hepatopancreatobiliary surgical cases was taken from Statistics Australia and the Medicare Benefit Schedule data over a ten year period from 2014 to 2023. Results A total of 2,281 major hepatopancreatobiliary cases were recorded in 2023 calendar year. 793 major pancreatic resections were performed, a 41% increase over the 2014 case volume. Major liver resections totaled 1,488 cases in 2023, a 21% increase over the same period. Available robotic case volume data between 2016 and 2023 demonstrates an increase from 91 to 230 cases. The most significant rise was seen in pancreatectomies, increasing from 35 to 103 cases (294% increase). The rise in liver resections was more modest, totally only 38 cases in 2023. Finally, robotic cholecystectomy rate remains low, with an annual figure of 90 cases in 2023. Conclusion Robotic hepatopancreatobiliary surgery has begun to see an upward trend in Australia in recent years, especially amongst pancreatic surgery. The continued uptake of robotic HPB surgery, especially in the public hospital system will require dedicated training and government support to maintain pace with the rest of the world.